LSE:NCYT (Novacyt S.A.)

About NCYT

Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. Its diagnostic products are used in LBC, oncology, microbiology, hematology, and serology testing. The company operates its business through the following business segments. Primerdesign is the designer, manufacturer, and marketer of molecular 'real-time' qPCR testing devices and reagents in the areas of infectious diseases based in Southampton, UK: Lab21 Product segment is a developer, manufacturer, and distributor of a large range of protein-based infectious disease IVD products; IT-IS International segment develops PCR devices for the life sciences and food testing industry and Corporate segment.
  • Novacyt S.A. (LSE: NCYT) Latest News

    man in shirt using computer and smiling while working in the office
    Investing Articles

    The Novacyt share price plunges 10%! Here’s why

    The Novacyt share price is plunging today as the company may have to revise its revenue figures lower due to…

    Read more »

    Investing Articles

    Novacyt or AstraZeneca: which biotech stock should I buy?

    Novacyt and AstraZeneca are two biotech stocks working in the realms of fighting the Covid-19 pandemic. Are either good long-term…

    Read more »

    Investing Articles

    Is the Novacyt (NCYT) share price crash a buying opportunity?

    The Novacyt (NCYT) share price crashed this month after the loss of a key contract. But is this a buying…

    Read more »

    Investing Articles

    The Novacyt share price is flying. Should I buy the rebound?

    The Novacyt share price is up by more than 15% today and the company has a number of new products.…

    Read more »

    Investing Articles

    The Novacyt share price has crashed: here’s what I’d do now

    The Novacyt share price fell by 40% on Friday. Roland Head looks at the outlook for the Covid-19 testing specialist…

    Read more »

    Investing Articles

    The NCYT share price exploded by 6,450% in 2020. Can it do it again?

    The NCYT share price was one of the highest performing stocks in 2020, rising by more than 64 times! Is…

    Read more »

    Investing Articles

    3 trending penny shares: hit, hold or fold?

    If I had to buy, hold or sell penny shares SYME, 4D Pharma and Novacyt, what would I do? Fool…

    Read more »

    Investing Articles

    Novacyt share price: should I buy the dip?

    The Novacyt share price has fallen 40% in one month. Roland Head asks if it's time to start buying despite…

    Read more »

    Investing Articles

    Novacyt shares: insiders are buying. Should I buy too?

    Since Novacyt shares have pulled back, a number of top-level directors have purchased stock. This suggests these insiders are confident,…

    Read more »

    Investing Articles

    Should I buy Novacyt shares for the long term or are they risky now?

    A £3,000 investment in January 2020 would have inflated to just over £257,000 with Novacyt. But the stock’s been volatile…

    Read more »

    Investing Articles

    Hargreaves Lansdown investors are buying BP, Novacyt and Boohoo shares. Should I?

    BP plc (LON:BP), Novacyt SA (LON:NCYT) and Boohoo Group plc (LON:BOO) shares topped the buy table last week. Should I…

    Read more »

    Investing Articles

    The Novacyt share price is flying: here’s what I’d do next

    Covid 19 testing is ramping up. Harshil Patel discusses a diagnostics leader and what the Novacyt share price might do…

    Read more »